MiniMed Group, Inc.

MMED Healthcare Medical Instruments & Supplies

MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.

17.89 0.27 −1.49%
Market cap
$5.1B
P/E
0.0×
Fwd P/E
27.8×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−3.09
Dividend safety
n/a

MiniMed Group, Inc. (MMED) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, MiniMed Group, Inc. (MMED) trades at a P/S ratio of 1.7×. Over the past ten years it has ranged from 0.0× (July 2026) to 2.2× (September 2026); the current reading is higher than 64% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2026 0.0× —
FY2025 0.0× —
FY2024 0.0× —

Quarterly newest first

Period P/S ratio Change
Jul 2026 1.7× —
Jan 2026 0.0× —
Jul 2025 0.0× —
Jan 2025 0.0× —

Against its own ten years

Low 0.0× High 2.2×
Ten-year median 0.0×
Current reading's percentile 64

P/S ratio against peers

Company P/S ratio
BLCO Bausch + Lomb Corporation compare 1.3×
NVST Envista Holdings Corporation compare 1.4×
MMED MiniMed Group, Inc. 1.7×
ICUI ICU Medical, Inc. compare 1.9×
STVN Stevanato Group S.p.A. compare 2.5×
TFX Teleflex Incorporated compare 2.9×
MMSI Merit Medical Systems, Inc. compare 3.3×
ATRC AtriCure, Inc. compare 5.0×
PLSE Pulse Biosciences, Inc compare 2,559×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on MMED